ADIPOGEN

Live / Registered — Registered and renewed (as of 31 May 2022)

What this means for you

Registered since 22 May 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 May 2022).

Record

Serial number
77636854
Registration number
4146965
Mark type
Stylized text
Filed
19 Dec 2008
Published for opposition
14 Jul 2009
Registered
22 May 2012
Next maintenance due
22 May 2022
Attorney of record
Rob G. Leach

Goods and services

  • Class 001 — Chemicals: Assays for research purposes; Biochemical proteins, enzymes and antibodies for scientific and medical research; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, polyclonal and monoclonal antibodies for in vitro scientific or research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting enzymes and proteins for laboratory or research use; Chemicals for use in the purification of proteins for in vitro use; Diagnostic kits for research and in vitro use consisting primarily of polyclonal and monoclonal antibodies, buffers [, and reagents ] to monitor proteins and reagents; Diagnostics, namely, diagnostic preparations and reagents other than for medical or veterinary purposes; Diagnostic preparations and reagents for scientific or research use; Diagnostic preparations and reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Protein arrays and nucleotide arrays for scientific and medical research; Reagent for chemical analyses; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Stem cells and stem cell reagents for research purposes; Testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for laboratory or research use; Testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for clinical or medical laboratory use
  • Class 005 — Pharmaceuticals: Biological preparations for medical purposes; Chemical reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of polyclonal and monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Diagnostic reagents for medicinal use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of obesity and diabetes and inflammatory disorders, for use in angiogenesis, dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders [ ; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and natural medicinal extracts derived from animal, plant and microorganism sources for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, obesity and diabetes, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Reagents and media for medical and veterinary diagnostic purposes ]

Owner

Prosecution history

  • 31 May 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
  • 31 May 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
  • 31 May 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
  • 26 May 2022 — TEAS SECTION 8 & 9 RECEIVED
  • 09 Sept 2021 — OFFICE ACTION ISSUED POU1
  • 09 Sept 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 24 Aug 2021 — TEAS SECTION 8 & 9 RECEIVED
  • 22 May 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 24 May 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
  • 24 May 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 24 May 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 10 May 2018 — TEAS SECTION 8 & 15 RECEIVED
  • 09 Aug 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 22 May 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 12 Feb 2014 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

View this trademark record on Marksy